Skip to Main Content

Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like a pleasant morning to lift the spirits. A cool breeze and warm sun are enveloping the Pharmalot campus as we hunker down and sift through our ever-growing to-do list. A familiar exercise, yes? Well, time to get cracking. So please join us for a daily ritual — a few cups of stimulation. Our choice today is Jack Daniel’s (yes, this is a caffeinated beverage for those of you unaware). And do keep us in mind if you hear something fascinating. Meanwhile, here are your tidbits. Dig in and have a grand day…

Moderna (MRNA) has applied for patents in South Africa relating to its Covid-19 vaccine, prompting fears the company could eventually seek to prevent a new African vaccine manufacturing hub from making its own version of the mRNA shot, Reuters reports. A Moderna spokesperson confirmed the patent filings, but said the move would not block vaccine distribution in Africa and reiterated an October 2020 pledge not to enforce its Covid-related patents during the coronavirus pandemic. But Moderna chief executive officer Stéphane Bancel told Reuters, “We have not decided yet for low- and middle-income countries.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment